Hematopoietic Stem Cell TransplantationTransplantation, AutologousPeripheral Blood Stem Cell TransplantationTransplantation, HomologousStem Cell TransplantationAntineoplastic Combined Chemotherapy ProtocolsTransplantation ConditioningCyclophosphamideCombined Modality TherapyStem CellsEtoposideTreatment OutcomeBone Marrow TransplantationHematopoietic Stem Cell MobilizationGraft SurvivalMultiple MyelomaGraft vs Host DiseaseGranulocyte Colony-Stimulating FactorAntigens, CD34VincristineCisplatinDoxorubicinHematologic NeoplasmsDisease-Free SurvivalLiver TransplantationSurvival AnalysisSurvival RateHematopoietic Stem CellsRemission InductionChemotherapy, AdjuvantAntineoplastic AgentsTransplantation ChimeraMesenchymal Stem Cell TransplantationSalvage TherapyTissue DonorsPrednisoneCord Blood Stem Cell TransplantationBleomycinHodgkin DiseaseMelphalanPrognosisRecurrenceRetrospective StudiesKidney TransplantationCell TransplantationMethotrexateEmbryonic Stem CellsMyeloablative AgonistsProcarbazineTime FactorsVinblastineFollow-Up StudiesFluorouracilBusulfanLymphoma, Non-HodgkinAdult Stem CellsMechlorethamineCarboplatinWhole-Body IrradiationHistocompatibility TestingLung NeoplasmsCytarabineDrug Administration ScheduleLeukemiaOrganoplatinum CompoundsImmunosuppressive AgentsNeoplasm StagingHematologic DiseasesVidarabineCarmustineHistocompatibilityNeoplasm Recurrence, LocalAntibodies, Monoclonal, HumanizedLeukemia, Myeloid, AcuteCell DifferentiationIfosfamideBreast NeoplasmsGraft vs Leukemia EffectHeart TransplantationPluripotent Stem CellsClinical Trials as TopicAntibodies, Monoclonal, Murine-DerivedTransplantation ImmunologyLung TransplantationLymphomaNeural Stem CellsProspective StudiesStem Cell NicheAntineoplastic Agents, AlkylatingPrecursor Cell Lymphoblastic Leukemia-LymphomaAntibodies, MonoclonalGraft RejectionMesenchymal Stromal CellsNeoplasm MetastasisLymphatic IrradiationHepatic Veno-Occlusive DiseaseActuarial AnalysisPaclitaxelDeoxycytidineOrgan Transplantation